Login / Signup

Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patients.

Yasumasa ShimasakiHiroaki MiyoshiKeisuke KawamotoNoriaki YoshidaTatsuzo MishinaKazutaka NakashimaTeppei ImamotoTakeshi SugioEriko YanagidaTakeharu KatoKyohei YamadaMai TakeuchiTakaharu SuzukiMayuko MoritsuboTakuya FurutaYoshitaka ImaizumiJun TakizawaKoji KatoJunji SuzumiyaRitsuro SuzukiKoichi Ohshima
Published in: Cancer medicine (2024)
The classification of PTCL-NOS into PTCL-TBX21 and PTCL-GATA3 is useful for predicting the prognosis of Japanese patients and stratifying the administration of tumor immune checkpoint inhibitors in clinical practice.
Keyphrases
  • clinical practice
  • transcription factor
  • deep learning